2003
DOI: 10.1016/mjd.2003.550
|View full text |Cite
|
Sign up to set email alerts
|

Current systemic therapies for psoriasis: where are we now?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
53
0
8

Year Published

2004
2004
2017
2017

Publication Types

Select...
3
2
1

Relationship

0
6

Authors

Journals

citations
Cited by 56 publications
(61 citation statements)
references
References 79 publications
0
53
0
8
Order By: Relevance
“…15 These actions result in a reduction in DNA synthesis, inhibition of mitosis, and a decrease in the proliferation of rapidly dividing cells. Methotrexate is known to decrease T and B cell function and suppress the secretion of cytokines (IL-1, interferon-gamma, TNF).…”
Section: Methotrexatementioning
confidence: 99%
See 4 more Smart Citations
“…15 These actions result in a reduction in DNA synthesis, inhibition of mitosis, and a decrease in the proliferation of rapidly dividing cells. Methotrexate is known to decrease T and B cell function and suppress the secretion of cytokines (IL-1, interferon-gamma, TNF).…”
Section: Methotrexatementioning
confidence: 99%
“…15 Acitretin is the active metabolite of etretinate, previously known as Tegison. While etretinate takes years to be eliminated from the body, acitretin elimination takes several months.…”
Section: Acitretinmentioning
confidence: 99%
See 3 more Smart Citations